CG Oncology, Inc. Common stock
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.28 |
2.44 |
85.60 |
244.59 |
445.99 |
739.72 |
| Przychód Δ r/r |
0.00% |
90.20% |
3414.69% |
185.75% |
82.34% |
65.86% |
| Przychód (min) |
0.41 |
0.59 |
85.60 |
244.59 |
107.57 |
178.42 |
| Przychód (max) |
2.15 |
4.28 |
85.60 |
244.59 |
784.40 |
1,301.01 |
| EBITDA (średnia) |
-1.28 |
-2.44 |
-85.60 |
-244.59 |
-445.99 |
-739.72 |
| EBIT (średnia) |
-1.28 |
-2.44 |
-85.60 |
-244.59 |
-445.99 |
-739.72 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-80.20 |
-116.29 |
-146.05 |
-64.95 |
5.87 |
123.49 |
| Zysk netto % |
-6263.69% |
-4775.09% |
-170.63% |
-26.56% |
1.32% |
16.69% |
| EPS (średnia) |
-1.27 |
-1.86 |
-1.80 |
-0.70 |
0.09 |
1.98 |
| Liczba analityków (Przychody) |
4 |
5 |
10 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
5 |
7 |
9 |
7 |
5 |
2 |
| symbol |
CGON |
CGON |
CGON |
CGON |
CGON |
CGON |